D. Wurm

Severe neurological outcomes after very early bilateral nephrectomies in patients with autosomal recessive polycystic kidney disease (ARPKD)

M. Marlais, M. Litwin, L. Weber, 2020, Scientific Reports.

Risk Factors for Early Dialysis Dependency in Autosomal Recessive Polycystic Kidney Disease

A. Anarat, S. Schmidt, S. Testa, 2018, The Journal of pediatrics.

Early childhood height-adjusted total kidney volume as a risk marker of kidney survival in ARPKD

M. Marlais, L. Weber, D. Mekahli, 2021, Scientific Reports.

ALG6-CDG: a recognizable phenotype with epilepsy, proximal muscle weakness, ataxia and behavioral and limb anomalies

G. Matthijs, R. Wevers, C. Thiel, 2016, Journal of Inherited Metabolic Disease.

Outbreak Report of Airborne Caterpillar Dermatitis in a Kindergarten

L. Gortner, S. Meyer, S. Gottschling, 2007, Dermatology.

Bone Fractures in Children and Young Adults With Type 1 Diabetes: Age Distribution, Fracture Location, and the Role of Glycemic Control

R. Holl, O. Semler, J. Hammersen, 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Early fatal course in siblings with CDG-Ia (caused by two novel mutations in the PMM2 gene): clinical, molecular and autopsy findings

L. Gortner, Yoo-Jin Kim, A. Lindinger, 2007, European Journal of Pediatrics.

A comparison of pediatric inflammatory multisystem syndrome temporarily-associated with SARS-CoV-2 and Kawasaki disease

M. Gappa, V. Soditt, R. Kitz, 2023, Scientific Reports.

Congenital disorders of glycosylation type Ia as a cause of mirror syndrome

L. Gortner, A. Lindinger, D. Wurm, 2007, Journal of Perinatology.

Arginine-vasopressin in catecholamine-refractory septic versus non-septic shock in extremely low birth weight infants with acute renal injury

L. Gortner, S. Meyer, S. Gottschling, 2006, Critical care.

Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial.

N. Teig, H. Biesalski, E. Giannopoulou, 2024, The Lancet. Respiratory medicine.